(149 days)
No
The summary describes a standard blood glucose monitoring system and data management software. There is no mention of AI or ML in the intended use, device description, or performance studies. The data management system is for review and evaluation, not automated analysis or decision-making using AI/ML.
No.
The device is intended for the measurement of glucose in blood samples to aid in diabetes management, but it is explicitly stated that it is "not intended to provide automated treatment guidance or decisions, nor is it to be used as a substitute for professional healthcare judgment." Therefore, it is a diagnostic or monitoring device, not a therapeutic one.
No
The "Intended Use / Indications for Use" section explicitly states: "The Telcare Blood Glucose Monitoring System is not indicated for the diagnosis or screening of diabetes or for neonatal use."
No
The device description explicitly states that the system consists of a Blood Glucose Meter (BGM), Test Strips, and Control Solutions, in addition to the Telserve Data Management System (software). The BGM is a hardware component that performs the glucose measurement.
Yes, the Telcare Blood Glucose Monitoring System is an IVD (In Vitro Diagnostic).
The Intended Use section explicitly states: "Testing is done outside the body (in vitro diagnostic use)." This directly identifies the device as an IVD.
N/A
Intended Use / Indications for Use
The Telcare Blood Glucose Monitoring system is intended for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertips, forearm, or palm. It is intended for lay use by persons with diabetes to aid in diabetes management. It is indicated for use at home (over the counter [OTC]) and should be used only by a single patient and should not be shared. Testing is done outside the body (in vitro diagnostic use). The Telcare Blood Glucose Monitoring System consists of the Telcare Blood Glucose Meter, Telcare Blood Glucose Test Strips, and Telcare Glucose Control Solutions. The Telcare Blood Glucose Monitoring system is not indicated for the diagnosis or screening of diabetes or for neonatal use. Palm and forearm testing should be done only during steady-state times when glucose is not changing rapidly. The Telcare Blood Glucose Meter uses cellular data transmission to send test results to Telcare's remote database.Telserve, and to receive messages from Telserve. The Telcare Blood Glucose Monitoring System is not intended to provide automated treatment guidance or decisions, nor is it to be used as a substitute for professional healthcare judgment.
The Telcare Blood Glucose Test Strips are to be used with the Telcare Blood Glucose Meter for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertips, palm, or forearm. These test strips are intended for lay use by persons with diabetes and should only be used by a single patient. They are not indicated for the diagnosis or screening of diabetes or for neonatal use. Palm and forearm testing should be done only during steady-state times when glucose is not changing rapidly.
Telcare Glucose Control Solutions: The purpose of the control solution test is to validate the performance of the Telcare Blood Glucose Monitoring System by using a test solution with a known amount of glucose. A control test that falls within the acceptable range indicates the user's technique is appropriate and the test strip and meter are functioning properly.
The Telserve Data Management System - Home Use (Telserve - Home) is an accessory to blood glucose monitoring systems for the review and evaluation of blood glucose test results to aid in diabetes management. Telserve collects data from blood glucose meters such as the Telcare BGM. Telserve - Home is not intended to provide automated treatment guidance or decisions, nor is it to be used as a substitute for professional healthcare judgment.
The Telserve Data Management System - Professional Use (Telserve - Pro) is an accessory to blood glucose monitoring systems for the review and evaluation of blood glucose test results to aid in diabetes management. Telserve collects data from blood glucose meters such as the Telcare BGM.
Product codes
NBW, CGA, JJX, JQP
Device Description
The Telcare Blood Glucose Monitoring System consists of the Telcare Blood Glucose Meter (BGM), Telcare Blood Glucose Test Strips, and Telcare Glucose Control Solutions. The Telcare BGM, when used with the Telcare Test Strips, quantitatively measures glucose in capillary whole blood. The Telcare Control Solutions verify the performance of the Telcare Test Strips. An embedded cellular module within the Telcare BGM enables wireless communication between the meter and Telcare's remote database, called the Telserve Data Management System (Telserve).
The Telserve Data Management System serves as an accessory to blood glucose meters to assist in the review and evaluation of blood glucose test results and related information to aid in diabetes management. The software system consists of two different levels of functionality: 1) Telserve Data Management System - Home Use and 2) Telserve Data Management System - Professional Use.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
fingertips, forearm, or palm
Indicated Patient Age Range
Not Found
Intended User / Care Setting
lay use by persons with diabetes / at home (over the counter [OTC])
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Telcare Blood Glucose Monitoring (BGM) System: A User Performance Study was conducted to evaluate the ease of use of the Telcare BGM and ease of understanding of the Telcare BGM user manual. An Accuracy and User Performance Study was conducted with professional and self-testing with fresh fingertip, palm and forearm testing. User control solution testing was conducted. A User Performance Study was conducted to evaluate the ease of use of the Telcare BGM Test Strip Insertion Process and ease of understanding of the Telcare BGM Test Strip Insertion instructions in the user manual.
Telserve Data Management System (Telserve): A User Performance Study was conducted to evaluate the ease of use of Telserve-Home and ease of understanding of the Telserve - Home user manual. A User Performance Study was conducted to evaluate the ease of use obtaining login credentials to Telserve and ease of understanding of the Telserve - Home user manual. A User Performance Study was conducted to evaluate the ease of use of Telserve-Pro, the ease of use of obtaining login credentials, and ease of understanding of the Telserve - Pro user manual.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Telcare BGM: Minimum Sample Volume, Linearity, Detection Limit, Precision, Hematocrit, Altitude, Humidity/Temperature, and Interfering Substances testing were done. Control Solution Qualification was conducted. EMC, Electrical Safety and FCC testing were conducted. Software verification and validation were done. All testing demonstrated safety and effectiveness of the Telcare Blood Glucose Monitoring system and substantial equivalence to the predicate.
Telserve Data Management System: Software verification and validation demonstrated safety and effectiveness of the Telserve remote database and substantial equivalence to the predicate.
Clinical Testing: The results show Telcare BGM System and Telserve showed substantial equivalence to the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
AutoSure Voice II Blood Glucose Monitoring System (BGM) - K102037, MCT-Diabetes (Data Management Software) - K073699, Gluco Track Blood Glucose Monitoring System (control solutions) – K062799
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1345 Glucose test system.
(a)
Identification. A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.(b)
Classification. Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
510(k) Summary
| Submitter: | Jonathan Javitt, M.D., M.P.H., Chief Executive Officer
Telcare, Inc.
2 Bethesda Metro Center, Suite 1350
Bethesda, MD, 20814 |
|--------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Jonathan Javitt, M.D., M.P.H., Chief Executive Officer
Telcare, Inc.
2 Bethesda Metro Center, Suite 1350
Bethesda, MD, 20814
Telephone: (240) 396-6003, Fax: 877-777-4710
Email: JJavitt@telcare.com |
| Date Prepared: | July 27, 2011 |
| Trade Names: | Telcare Blood Glucose Monitoring System, Telserve Data Management
System, Telcare Blood Glucose Test Strips, Telcare Glucose Control Solutions |
| Classification
Names: | Glucose test system, 21 CFR 862.1345, Class II
Quality control material (assayed and unassayed), 21 CFR 862.1600, Class I
Calculator/data processing module for clinical use, 21 CFR 862.2100, Class I
Exempt (non exempt is associated with blood glucose monitoring system) |
| Product Codes: | NBW, CGA, JJX, JQP |
| Predicate
Devices: | AutoSure Voice II Blood Glucose Monitoring System (BGM) - K102037,
MCT-Diabetes (Data Management Software) - K073699, Gluco Track Blood
Glucose Monitoring System (control solutions) – K062799 |
| Device
Description: | The Telcare Blood Glucose Monitoring System consists of the Telcare Blood
Glucose Meter (BGM), Telcare Blood Glucose Test Strips, and Telcare
Glucose Control Solutions. The Telcare BGM, when used with the Telcare
Test Strips, quantitatively measures glucose in capillary whole blood. The
Telcare Control Solutions verify the performance of the Telcare Test Strips.
An embedded cellular module within the Telcare BGM enables wireless
communication between the meter and Telcare's remote database, called the
Telserve Data Management System (Telserve).
The Telserve Data Management System serves as an accessory to blood
glucose meters to assist in the review and evaluation of blood glucose test
results and related information to aid in diabetes management. The software
system consists of two different levels of functionality: 1) Telserve Data
Management System - Home Use and 2) Telserve Data Management System - |
| Intended Use: | Telcare Blood Glucose Monitoring System |
| | The Telcare Blood Glucose Monitoring system is intended for the quantitative |
| | measurement of glucose in fresh capillary whole blood samples drawn from |
| | the fingertips, forearm, or palm. It is intended for lay use by persons with |
| | diabetes to aid in diabetes management. It is indicated for use at home (over |
| | the counter [OTC]) and should be used only by a single patient and should not |
| | be shared. Testing is done outside the body (in vitro diagnostic use). The |
| | Telcare Blood Glucose Monitoring System consists of the Telcare Blood |
| | Glucose Meter, Telcare Blood Glucose Test Strips, and Telcare Glucose |
| | Control Solutions. The Telcare Blood Glucose Monitoring system is not |
| | indicated for the diagnosis or screening of diabetes or for neonatal use. Palm |
| | and forearm testing should be done only during steady-state times when |
| | glucose is not changing rapidly. The Telcare Blood Glucose Meter uses |
| | cellular data transmission to send test results to Telcare's remote database, |
| | Telserve, and to receive messages from Telserve. The Telcare Blood Glucose |
| | Monitoring System is not intended to provide automated treatment guidance or |
| | decisions, nor is it to be used as a substitute for professional healthcare |
| | judgment. |
| | Telcare Blood Glucose Test Strips |
| | The Telcare Blood Glucose Test Strips are to be used with the Telcare Blood |
| | Glucose Meter for the quantitative measurement of glucose in fresh capillary |
| | whole blood samples drawn from the fingertips, palm, or forearm. These test |
| | strips are intended for lay use by persons with diabetes and should only be |
| | used by a single patient. They are not indicated for the diagnosis or screening |
| | of diabetes or for neonatal use. Palm and forearm testing should be done only |
| | during steady-state times when glucose is not changing rapidly. |
| | |
| | Telcare Glucose Control Solutions |
| | The purpose of the control solution test is to validate the performance of the |
| | Telcare Blood Glucose Monitoring System by using a test solution with a |
| | known amount of glucose. A control test that falls within the acceptable range |
| | indicates the user's technique is appropriate and the test strip and meter are |
| | functioning properly. |
1
JUL 2 8 2011
1
510(k) Summary (Cont'd)
2
510(k) Summary (Cont'd)
| Intended Use
(Cont'd) | The Telserve Data Management System - Home Use (Telserve - Home) is an accessory to blood glucose monitoring systems for the review and evaluation of blood glucose test results to aid in diabetes management. Telserve collects data from blood glucose meters such as the Telcare BGM. Telserve - Home is not intended to provide automated treatment guidance or decisions, nor is it to be used as a substitute for professional healthcare judgment.
The Telserve Data Management System - Professional Use (Telserve - Pro) is an accessory to blood glucose monitoring systems for the review and evaluation of blood glucose test results to aid in diabetes management. Telserve collects data from blood glucose meters such as the Telcare BGM. |
|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Technological
Characteristics | The Telcare Blood Glucose Monitoring System consists of a glucose meter that can wirelessly transmit data to a remote database using standard cellular technology embedded within the glucose meter. The meter uses biosensor test strips. Telserve Data Management System consists entirely of software run on a central server. |
| Non-Clinical
Testing | Telcare BGM: Minimum Sample Volume, Linearity, Detection Limit, Precision, Hematocrit, Altitude, Humidity/Temperature, and Interfering Substances testing were done. Control Solution Qualification was conducted. EMC, Electrical Safety and FCC testing were conducted. Software verification and validation were done. All testing demonstrated safety and effectiveness of the Telcare Blood Glucose Monitoring system and substantial equivalence to the predicate.
Telserve Data Management System: Software verification and validation demonstrated safety and effectiveness of the Telserve remote database and substantial equivalence to the predicate. |
·
:
3
510(k) Summary (Cont'd)
: ****
| Clinical | Telcare Blood Glucose Monitoring (BGM) System: |
|---|---|
| Testing: | A User Performance Study was conducted to evaluate the ease of use of the |
| Telcare BGM and ease of understanding of the Telcare BGM user manual. | |
| An Accuracy and User Performance Study was conducted with | |
| professional and self-testing with fresh fingertip, palm and forearm testing. | |
| User control solution testing was conducted. | |
| A User Performance Study was conducted to evaluate the ease of use of the | |
| Telcare BGM Test Strip Insertion Process and ease of understanding of the | |
| Telcare BGM Test Strip Insertion instructions in the user manual. | |
| Telserve Data Management System (Telserve): | |
| A User Performance Study was conducted to evaluate the ease of use of | |
| Telserve-Home and ease of understanding of the Telserve - Home user | |
| manual. | |
| A User Performance Study was conducted to evaluate the ease of use | |
| obtaining login credentials to Telserve and ease of understanding of the | |
| Telserve - Home user manual. | |
| A User Performance Study was conducted to evaluate the ease of use of | |
| Telserve-Pro, the ease of use of obtaining login credentials, and ease of | |
| understanding of the Telserve - Pro user manual. | |
| The results show Telcare BGM System and Telserve showed substantial | |
| equivalence to the predicate devices. | |
| Conclusion: | The Telcare Blood Glucose Monitoring System and its accessory Telserve |
| Data Management System are substantially equivalent to their predicate | |
| devices. |
4
Public Health Service
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/2 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo is a circular emblem with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread, clutching a staff with a snake wrapped around it, which is a symbol of medicine and healing.
Food & Drug Administration 10903 New Hampshire Avenue Building 66 Silver Spring, MD 20993
JUL 2 8 2011
Telcare, Incorporated c/o Dr. Jonathan C. Javitt Chief Executive Officer 3 Bethesda Metro Center Suite 430 Bethesda, MD 20814
Re: K110571
·
Trade Name: Telcare Blood Glucose Monitoring System, Telserve Data Management System - Home Use, Telserve Data Management System - Professional Use
Regulation Number: 21 CFR §862.1345 Regulation Name: Glucose Test System Regulatory Class: Class II Product Codes: NBW, CGA, JJX, JQP Dated: July 8, 2011 Received: July 11, 2011
Dear Dr. Javitt:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not. limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
5
Page 2 -
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
C.C.
Courtney Harper, Ph.D. Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
いなき
Enclosure
6
Indications for Use Statement
510(k) Number (if known): K110571
Telcare Blood Glucose Monitoring System Device Name: Telserve Data Management System - Home Use Telserve Data Management System - Professional Use
Indications for Use:
Telcare Blood Glucose Monitoring System
The Telcare Blood Glucose Monitoring system is intended for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertips, forearm, or palm. It is intended for lay use by persons with diabetes to aid in diabetes management. It is indicated for use at home (over the counter [OTC]) and should be used only by a single patient and should not be shared. Testing is done outside the body (in vitro diagnostic use). The Telcare Blood Glucose Monitoring System consists of the Telcare Blood Glucose Meter, Telcare Blood Glucose Test Strips, and Telcare Glucose Control Solutions. The Telcare Blood Glucose Monitoring system is not indicated for the diagnosis or screening of diabetes or for neonatal use. Palm and forearm testing should be done only during steady-state times when glucose is not changing rapidly. The Telcare Blood Glucose Meter uses cellular data transmission to send test results to Telcare's remote database.Telserve, and to receive messages from Telserve. The Telcare Blood Glucose Monitoring System is not intended to provide automated treatment guidance or decisions, nor is it to be used as a substitute for professional healthcare judgment.
Telcare Blood Glucose Test Strips
The Telcare Blood Glucose Test Strips are to be used with the Telcare Blood Glucose Meter for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertips, palm, or forearm. These test strips are intended for lay use by persons with diabetes and should only be used by a single patient. They are not indicated for the diagnosis or screening of diabetes or for neonatal use. Palm and forearm testing should be done only during steady-state times when glucose is not changing rapidly.
Prescription Use X (21 CFR Part 801 Subpart D) And/Or
Over the Counter Use X (21 CFR Part 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE; CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)
Division Sign Off
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K110571
7
510(k) Number (if known): K110571
Telcare Glucose Control Solutions
The purpose of the control solution is to validate the performance of the Telcare Blood Glucose Monitoring System by using a test solution with a known amount of glucose. A control test that falls within the acceptable range indicates the user's technique is appropriate and the test strip and meter are functioning properly.
Telserve Data Management System - Home Use
The Telserve Data Management System - Home Use (Telserve - Home) is an accessory to blood glucose monitoring systems for the review and evaluation of blood glucose test results to aid in diabetes management. Telserve collects data from blood glucose meters such as the Telcare BGM. Telserve - Home is not intended to provide automated treatment guidance or decisions, nor is it to be used as a substitute for professional healthcare judgment.
Telserve Data Management System - Professional Use
The Telserve Data Management System - Professional Use (Telserve - Pro) is an accessory to blood glucose monitoring systems for the review and evaluation of blood glucose test results to aid in diabetes management. Telserve collects data from blood glucose meters such as the Telcare BGM.
Prescription Use ___ X (21 CFR Part 801 Subpart D) And/Or
Over the Counter Use X (21 CFR Part 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE; CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)
Division Sign-Off
acting
Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) A110531/